Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The main objective of this study is to evaluate the safety, tolerability and pharmacokinetics
of Cerebril™ in Cerebral Amyloid Angiopathy (CAA) patients who have had lobar cerebral
hemorrhage.
Phase:
Phase 2
Details
Lead Sponsor:
Bellus Health Inc
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)